REQUEST A DEMO
Total
USD $0.00
Search more companies

Quanil Pharma S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Quanil Pharma S.A.S. Profile Updated: May 19, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Quanil Pharma S.A.S. is an enterprise located in Colombia, with the main office in Medellin. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on October 31, 2018. The total number of employees is currently 5 (2023). Its’ total assets recorded a growth of 70.99%.

Headquarters
Carrera 43 B 16 95 Oficina 1010
Medellin; Antioquia;

Contact Details: Purchase the Quanil Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Quanil Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Quanil Pharma S.A.S. report to view the information.
Incorporation Date:
October 31, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Quanil Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Total assets
70.99%
Total equity
40.47%
Quick Ratio
-4.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?